181 related articles for article (PubMed ID: 11739668)
1. Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells.
Foley HD; Otero M; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2002 Jan; 76(1):19-31. PubMed ID: 11739668
[TBL] [Abstract][Full Text] [Related]
2. Recombinant rabies virus as potential live-viral vaccines for HIV-1.
Schnell MJ; Foley HD; Siler CA; McGettigan JP; Dietzschold B; Pomerantz RJ
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3544-9. PubMed ID: 10706640
[TBL] [Abstract][Full Text] [Related]
3. Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.
McGettigan JP; Foley HD; Belyakov IM; Berzofsky JA; Pomerantz RJ; Schnell MJ
J Virol; 2001 May; 75(9):4430-4. PubMed ID: 11287595
[TBL] [Abstract][Full Text] [Related]
4. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
[TBL] [Abstract][Full Text] [Related]
5. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.
Boritz E; Gerlach J; Johnson JE; Rose JK
J Virol; 1999 Aug; 73(8):6937-45. PubMed ID: 10400792
[TBL] [Abstract][Full Text] [Related]
6. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
Johnson JE; Schnell MJ; Buonocore L; Rose JK
J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
[TBL] [Abstract][Full Text] [Related]
7. Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.
Mebatsion T; Conzelmann KK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11366-70. PubMed ID: 8876141
[TBL] [Abstract][Full Text] [Related]
8. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ
J Virol; 2003 Oct; 77(20):10889-99. PubMed ID: 14512539
[TBL] [Abstract][Full Text] [Related]
9. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene.
Sakamoto T; Ushijima H; Okitsu S; Suzuki E; Sakai K; Morikawa S; Müller WE
J Virol Methods; 2003 Dec; 114(2):159-66. PubMed ID: 14625051
[TBL] [Abstract][Full Text] [Related]
11. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ
Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
13. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
14. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells.
Mebatsion T; Finke S; Weiland F; Conzelmann KK
Cell; 1997 Sep; 90(5):841-7. PubMed ID: 9298896
[TBL] [Abstract][Full Text] [Related]
15. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
McGettigan JP; Pomerantz RJ; Siler CA; McKenna PM; Foley HD; Dietzschold B; Schnell MJ
J Virol; 2003 Jan; 77(1):237-44. PubMed ID: 12477829
[TBL] [Abstract][Full Text] [Related]
16. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
McKenna PM; Aye PP; Dietzschold B; Montefiori DC; Martin LN; Marx PA; Pomerantz RJ; Lackner A; Schnell MJ
J Virol; 2004 Dec; 78(24):13455-9. PubMed ID: 15564456
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
[TBL] [Abstract][Full Text] [Related]
20. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
Brown BK; Darden JM; Tovanabutra S; Oblander T; Frost J; Sanders-Buell E; de Souza MS; Birx DL; McCutchan FE; Polonis VR
J Virol; 2005 May; 79(10):6089-101. PubMed ID: 15857994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
